KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2022-06-16+91,000→ 91,000 totalExercise: $22.48From: 2023-06-16Exp: 2032-06-16→ Common Stock (91,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.